Hemorrhagic Bowel Syndrome (HBS) / Jejunal Hemorrhage Syndrome

Hemorrhagic Bowel Syndrome (HBS), also known as Jejunal Hemorrhage Syndrome, is an acute, often fatal, sporadic disease of adult dairy cattle, characterized by intraluminal hemorrhage and obstruction of the small intestine, primarily the jejunum. The condition is typified by sudden onset of severe depression, marked reduction in milk yield, abdominal distension, and the passage of dark, tarry feces (melena). HBS is a distinct clinical entity from other causes of intestinal obstruction or enteritis, with a unique pathophysiology involving Clostridium perfringens type A and its beta2 toxin, leading to localized intestinal necrosis and hemorrhage. The disease predominantly affects high-producing dairy cows in early lactation, often within the first 90 days of lactation, and is associated with significant economic losses due to high mortality, culling, and reduced milk production. HBS is also referred to as jejunal hemorrhage syndrome, hemorrhagic enteritis, or simply 'blood gut' in some regions. The condition is a medical and surgical emergency, with a guarded prognosis, and requires prompt recognition and aggressive intervention to optimize outcomes.

The primary etiological agent of Hemorrhagic Bowel Syndrome is Clostridium perfringens type A, which produces alpha toxin and, importantly, beta2 toxin (CPB2). The beta2 toxin is a pore-forming toxin that damages the intestinal epithelium, leading to increased vascular permeability, hemorrhage, and necrosis. While C. perfringens type A is a normal inhabitant of the bovine gastrointestinal tract, certain dietary and environmental factors can trigger its overgrowth and toxin production. High-concentrate, low-fiber diets, particularly those rich in rapidly fermentable carbohydrates (starch), are strongly associated with the disease, as they alter the intestinal microenvironment, favoring clostridial proliferation. Other potential contributing factors include sudden changes in diet, mycotoxins (e.g., fumonisins, aflatoxins), and possibly viral infections such as bovine viral diarrhea virus (BVDV) or coronavirus, which may damage the intestinal mucosa and predispose to clostridial invasion. However, the exact etiological cascade remains incompletely understood, and HBS is considered a multifactorial disease. The role of Clostridium perfringens type A and its toxins is supported by isolation of the organism from intestinal contents and detection of beta2 toxin in affected tissues, although the presence of the organism alone is not sufficient for diagnosis, as it can be found in healthy cattle.

Hemorrhagic Bowel Syndrome is predominantly a disease of adult dairy cattle, with the highest incidence in high-producing cows during the first 90 days of lactation. It is rarely reported in beef cattle, heifers, or dry cows. The disease occurs sporadically, with a herd-level morbidity typically less than 1-2%, but the case fatality rate is high, ranging from 50% to 100% in untreated cases. The economic impact is substantial due to death loss, culling, and reduced milk production in affected cows. Seasonality has been reported, with a higher incidence in the winter months in some regions, possibly related to feeding practices and confinement. Herd-level risk factors include high milk yield, feeding total mixed rations (TMR) with high starch content, inadequate effective fiber, and poor feed bunk management. The disease is more common in herds with high stocking density and limited access to feed, which may lead to slug feeding and rapid consumption of fermentable carbohydrates. There is no clear breed predisposition, but Holstein-Friesian cows are overrepresented due to their prevalence in dairy operations. The sporadic nature of HBS makes it difficult to predict, but outbreaks have been reported, suggesting a common dietary or environmental trigger.

The pathophysiology of Hemorrhagic Bowel Syndrome involves a cascade of events initiated by the overgrowth of Clostridium perfringens type A in the small intestine, particularly the jejunum. The organism produces alpha toxin (phospholipase C) and beta2 toxin, which act synergistically to damage the intestinal epithelium. Beta2 toxin binds to the enterocyte membrane, forming pores that disrupt cellular integrity, leading to cell death and desquamation. This results in increased intestinal permeability, allowing the extravasation of blood and plasma into the lumen. The toxins also induce a localized inflammatory response, with infiltration of neutrophils and macrophages, further exacerbating tissue damage. The affected segment of jejunum becomes hemorrhagic, edematous, and necrotic, with the formation of a blood clot that can obstruct the lumen. The obstruction leads to proximal intestinal distension with fluid and gas, causing abdominal pain and tympany. The systemic effects include endotoxemia and sepsis due to translocation of bacteria and toxins across the damaged mucosal barrier, leading to systemic inflammatory response syndrome (SIRS), shock, and disseminated intravascular coagulation (DIC). The rapid progression of the disease is attributed to the potent toxins and the limited capacity of the intestine to repair the extensive damage. The exact trigger for clostridial overgrowth is not fully understood, but dietary starch overload is a key factor, as it provides a substrate for rapid bacterial growth and alters the intestinal pH and motility.

Several intrinsic and extrinsic factors predispose cattle to Hemorrhagic Bowel Syndrome. Intrinsic factors include high milk production, which is associated with increased feed intake and a higher risk of ruminal acidosis and intestinal dysbiosis. Parity and genetics may also play a role, as high-producing cows are more susceptible. The transition period and early lactation are critical times when cows experience negative energy balance, immunosuppression, and metabolic stress, making them more vulnerable to infectious agents. Extrinsic factors are primarily related to nutrition and management. Feeding diets with high levels of rapidly fermentable carbohydrates (starch) and low effective fiber increases the risk of ruminal acidosis and alters the intestinal microbiome. Sudden changes in diet, such as switching from a high-forage to a high-concentrate ration, can precipitate the disease. Poor feed bunk management, including infrequent feeding, feed sorting, and inadequate bunk space, can lead to slug feeding and excessive intake of concentrates. Other management factors include overcrowding, poor ventilation, and dirty bedding, which increase stress and exposure to pathogens. Mycotoxin contamination of feed, particularly fumonisins and aflatoxins, has been implicated as a trigger. Additionally, concurrent diseases such as bovine viral diarrhea (BVD) or salmonellosis may compromise the intestinal barrier and predispose to clostridial overgrowth.

The clinical signs of Hemorrhagic Bowel Syndrome are acute and often severe. Affected cows are typically found recumbent or severely depressed, with a sudden and dramatic drop in milk production. The cow may exhibit signs of abdominal pain, such as kicking at the abdomen, teeth grinding, and restlessness. The rectal temperature may be normal or elevated, but can be subnormal in cases of shock. The heart rate is often increased (tachycardia), and the respiratory rate may be elevated. The mucous membranes are pale or injected, and the capillary refill time is prolonged, indicating poor perfusion. The abdomen is often distended, and auscultation of the gastrointestinal tract reveals reduced or absent rumen and intestinal motility. Percussion and auscultation (ping) may reveal a tympanic resonance over the right abdomen, suggestive of intestinal obstruction. Fecal examination often reveals dark, tarry, malodorous feces (melena), which is a hallmark sign. However, in early cases, feces may be normal or reduced in quantity. As the disease progresses, the cow may become recumbent, and signs of shock, such as cold extremities and weak pulse, become evident. Without prompt intervention, death can occur within 24 to 48 hours. In some cases, the disease may be less severe, with cows showing only mild depression and reduced milk yield, but these cases are rare and often progress to the fulminant form.

Differential diagnoses for Hemorrhagic Bowel Syndrome include other causes of acute abdominal pain, intestinal obstruction, and enteritis in cattle. Key differentials include: 1) Abomasal displacement (left or right) – characterized by a high-pitched ping on auscultation over the left or right abdomen, respectively, and a characteristic 'tinkling' sound; abomasal displacement is more common in early lactation and is not typically associated with melena. 2) Intestinal intussusception – presents with acute abdominal pain, a palpable mass on rectal examination, and a 'sausage-shaped' mass on ultrasonography; melena may be present but is less common. 3) Volvulus of the small intestine – causes rapid onset of severe colic, abdominal distension, and shock; surgical exploration is required for diagnosis. 4) Salmonellosis – causes diarrhea, fever, and dehydration, but melena is less common; fecal culture can confirm. 5) Bovine viral diarrhea (BVD) – can cause diarrhea, oral lesions, and immunosuppression; diagnosis via PCR or antigen detection. 6) Coccidiosis – primarily affects young cattle, causing bloody diarrhea and tenesmus; fecal flotation can identify oocysts. 7) Traumatic reticuloperitonitis (hardware disease) – causes fever, anorexia, and abdominal pain, but melena is not typical; diagnosis via ultrasonography and response to magnet. 8) Peritonitis – can cause abdominal pain and distension, but melena is rare; abdominocentesis reveals exudative fluid. 9) Clostridial enterotoxemia (e.g., C. perfringens type C) – more common in calves, causing hemorrhagic enteritis; diagnosis via toxin detection. 10) Intestinal neoplasia – rare, but can cause obstruction and melena; diagnosis via ultrasonography or exploratory laparotomy.

The diagnostic approach to Hemorrhagic Bowel Syndrome involves a stepwise process. First, obtain a thorough history, including stage of lactation, diet, and recent management changes. Perform a complete physical examination, with emphasis on vital parameters, abdominal auscultation, percussion, and rectal palpation. The presence of melena on rectal examination is highly suggestive of HBS. Next, perform a complete blood count (CBC) and serum biochemistry profile, which may reveal hemoconcentration, leukopenia or leukocytosis, and elevated liver enzymes. Rumen fluid analysis may show a pH below 5.5, indicating ruminal acidosis, which is a predisposing factor. Abdominocentesis may be performed to rule out peritonitis; in HBS, the fluid is typically serosanguinous or hemorrhagic. Ultrasonography of the abdomen can be helpful to identify distended, fluid-filled loops of small intestine with thickened walls, and to rule out other causes of obstruction. Radiography is rarely used in adult cattle due to size, but may be useful in calves. Definitive diagnosis is often made at surgery (exploratory laparotomy) or necropsy, where the characteristic segmental hemorrhagic and necrotic jejunum is identified. In surgical cases, the affected segment appears dark red to black, with a thickened wall and a blood clot within the lumen. A fecal sample can be submitted for Clostridium perfringens culture and toxin detection, but this is not always conclusive. The diagnostic algorithm should be rapid, as early surgical intervention may improve the prognosis.

Laboratory findings in Hemorrhagic Bowel Syndrome are non-specific but supportive. A complete blood count (CBC) may reveal hemoconcentration (elevated packed cell volume) due to dehydration, and leukopenia or leukocytosis with a left shift, indicating an inflammatory response. Serum biochemistry may show elevated liver enzymes (aspartate aminotransferase, gamma-glutamyl transferase) and bilirubin, reflecting hepatic damage. Blood urea nitrogen and creatinine may be elevated due to dehydration and prerenal azotemia. Electrolyte imbalances, such as hypokalemia, hypochloremia, and metabolic alkalosis, may be present due to sequestration of fluid in the intestine and loss of chloride. Blood beta-hydroxybutyrate (BHB) levels may be elevated (>1.2 mmol/L) in cows with concurrent ketosis, which is a common comorbidity in early lactation. Rumen fluid analysis may show a pH below 5.5, reduced protozoal motility, and a positive methylene blue reduction test, indicating ruminal acidosis. Fecal occult blood testing is positive, and the feces may be grossly bloody. In cases with systemic involvement, coagulation parameters may be abnormal, indicating disseminated intravascular coagulation (DIC), with prolonged prothrombin time and partial thromboplastin time, and elevated D-dimers. Milk production records will show a sudden drop, and milk composition may be altered, with an increase in somatic cell count (SCC) if mastitis is concurrent.

Imaging modalities are valuable in the diagnostic workup of Hemorrhagic Bowel Syndrome. Ultrasonography of the abdomen is the most useful imaging tool in cattle. In HBS, the affected small intestine appears as distended, fluid-filled loops with thickened, edematous walls, often with a 'target' or 'doughnut' appearance on cross-section. The wall thickness may exceed 5 mm, and the lumen may contain echogenic material consistent with blood clots. The motility of the affected segment is reduced or absent. Ultrasonography can also help rule out other conditions such as abomasal displacement, intussusception, or peritonitis. In cases of intussusception, a characteristic 'bull's eye' or 'target' lesion is seen. Radiography is of limited value in adult cattle due to their size, but in calves, it can be used to identify intestinal obstruction or intussusception. Thoracic radiography may be performed to rule out pneumonia, which can be a concurrent finding. Endoscopy is not commonly used in cattle for intestinal evaluation, but laparoscopy can be used to visualize the abdominal cavity and obtain biopsies. In surgical cases, exploratory laparotomy provides the most definitive imaging, allowing direct visualization of the affected jejunum.

Cytological and histopathological examination of tissues and fluids can aid in the diagnosis of Hemorrhagic Bowel Syndrome. Peritoneal fluid analysis via abdominocentesis may reveal a serosanguinous or hemorrhagic fluid with an elevated nucleated cell count, predominantly neutrophils, and the presence of intracellular and extracellular bacteria. The fluid may have a high protein concentration and a low glucose concentration, indicating a septic exudate. Histopathology of the affected jejunum, obtained at surgery or necropsy, shows severe hemorrhagic necrosis of the mucosa and submucosa, with extensive infiltration of neutrophils and macrophages. The intestinal villi are blunted or destroyed, and the lamina propria is edematous and hemorrhagic. The submucosal blood vessels are congested and thrombosed, and there is evidence of fibrinoid necrosis of the vessel walls. Immunohistochemistry can be used to detect Clostridium perfringens beta2 toxin in the affected tissues, which is a key diagnostic feature. In some cases, the liver may show fatty change, and the kidneys may show tubular necrosis, reflecting systemic effects. The histopathological findings are characteristic and can differentiate HBS from other causes of enteritis or obstruction.

Treatment of Hemorrhagic Bowel Syndrome is challenging and often requires a combination of medical and surgical interventions. The primary goals are to stabilize the cow, correct fluid and electrolyte imbalances, control pain and inflammation, and address the intestinal obstruction. Immediate fluid therapy is essential, using isotonic crystalloids such as lactated Ringer's solution or normal saline, administered intravenously at a rate of 20-40 mL/kg/hour initially, then adjusted based on hydration status. Hypertonic saline (7.5% NaCl) at a dose of 4-5 mL/kg IV can be used for rapid volume expansion, followed by isotonic fluids. Oral fluids may be given via stomach tube if the cow is not obstructed, but in HBS, oral fluids may be contraindicated due to the risk of increasing intestinal distension. Non-steroidal anti-inflammatory drugs (NSAIDs) such as flunixin meglumine (1.1-2.2 mg/kg IV) or meloxicam (0.5 mg/kg IV or SC) are used to reduce inflammation and pain. Antibiotics are indicated to control secondary bacterial infection and sepsis; options include ceftiofur (2.2 mg/kg SC or IM q24h), oxytetracycline (10-20 mg/kg IV or IM q24h), or ampicillin (10-20 mg/kg IM or SC q12h). Surgical intervention, via exploratory laparotomy, is often necessary to remove the affected segment of jejunum (resection and anastomosis) or to manually break down the blood clot if it is not extensive. However, surgery is often not feasible due to the poor condition of the cow and the high risk of complications. In cases where surgery is not possible, medical management may be attempted, but the prognosis is grave. Supportive care includes providing a comfortable environment, monitoring vital signs, and offering palatable feed once the cow stabilizes.

The prognosis for Hemorrhagic Bowel Syndrome is generally poor to grave, with a high mortality rate. The case fatality rate is reported to be between 50% and 100%, even with treatment. Factors that worsen the prognosis include the severity of clinical signs, the presence of shock, the extent of intestinal necrosis, and the delay in treatment. Cows that undergo surgical resection of the affected segment have a better prognosis than those treated medically, but the survival rate is still low, with many cows dying in the immediate postoperative period or being culled due to poor milk production. The long-term prognosis for surviving cows is also guarded, as they may experience reduced milk yield, reproductive problems, and an increased risk of recurrence. Negative prognostic indicators include a heart rate greater than 100 beats per minute, a rectal temperature below 38°C or above 40°C, a packed cell volume greater than 45%, and the presence of disseminated intravascular coagulation. Early recognition and aggressive treatment may improve the chances of survival, but the overall prognosis remains poor.

Follow-up care for cows that survive Hemorrhagic Bowel Syndrome is crucial to monitor recovery and prevent complications. In the immediate post-treatment period, cows should be monitored closely for signs of shock, dehydration, and electrolyte imbalances. Serial blood work, including a CBC, serum biochemistry, and blood gas analysis, should be performed daily until the cow is stable. Rumen fluid pH should be monitored to ensure it is within the normal range (6.0-7.0). Milk yield should be recorded daily, and cows should be gradually reintroduced to a balanced ration, starting with high-quality forage and slowly increasing concentrate. The ration should be formulated to avoid excessive starch and ensure adequate effective fiber. Cows should be observed for signs of recurrence, such as a drop in milk yield, depression, or changes in fecal consistency. Herd-level follow-up includes reviewing the feeding program, feed bunk management, and overall cow comfort. A transition cow audit may be performed to identify and correct risk factors. The herd veterinarian should work with the nutritionist to adjust the ration, if necessary, and consider the use of feed additives such as probiotics or yeast to stabilize the rumen. Cows that have had HBS should be monitored for reproductive performance, and if they are not pregnant within a reasonable time, they may be culled.

Clinical pearls for Hemorrhagic Bowel Syndrome include: 1) The presence of melena on rectal examination is a key diagnostic clue, but it may not be present in early cases; therefore, a high index of suspicion is needed in high-producing cows with acute abdominal pain. 2) Ultrasonography is a valuable tool to identify the characteristic thickened, fluid-filled loops of jejunum, and can be performed on farm. 3) Early surgical intervention, if feasible, may improve the prognosis, but the decision to operate should be based on the cow's condition and the availability of surgical facilities. 4) Aggressive fluid therapy and NSAIDs are essential to manage shock and inflammation. 5) The use of hypertonic saline can be life-saving in cases of severe hypovolemia. Pitfalls include: 1) Delaying treatment while waiting for diagnostic tests, as the disease progresses rapidly. 2) Administering oral fluids or medications in cows with intestinal obstruction, which can worsen the condition. 3) Using antibiotics that are ineffective against Clostridium perfringens, such as penicillin, which is not effective against type A. 4) Failing to address the underlying dietary risk factors, leading to recurrence in the herd. 5) Overlooking concurrent conditions such as ketosis or mastitis, which can complicate the clinical picture and worsen the prognosis.

Current drug protocols for Hemorrhagic Bowel Syndrome are based on Plumb's Veterinary Drug Handbook and AABP guidelines. Fluid therapy: Isotonic crystalloids (Lactated Ringer's or 0.9% NaCl) IV at 20-40 mL/kg/hour initially, then 10-20 mL/kg/hour for maintenance. Hypertonic saline (7.5% NaCl) IV at 4-5 mL/kg over 5-10 minutes, followed by isotonic fluids. NSAIDs: Flunixin meglumine (Banamine) 1.1-2.2 mg/kg IV q12-24h for 1-3 days; Meloxicam (Metacam) 0.5 mg/kg IV or SC once, may repeat in 48h. Antibiotics: Ceftiofur (Excede) 2.2 mg/kg SC or IM q24h for 3-5 days; Oxytetracycline (Liquamycin) 10-20 mg/kg IV or IM q24h for 3-5 days; Ampicillin (Polyflex) 10-20 mg/kg IM or SC q12h for 3-5 days. For Clostridium perfringens, penicillin G procaine (22,000 IU/kg IM q12h) may be used, but resistance is common; metronidazole (10 mg/kg IV q12h) is an alternative but is not approved in cattle. Supportive therapy: Calcium borogluconate 23% solution IV at 500 mL per cow for hypocalcemia, if present; Propylene glycol 300-500 mL orally q12h for ketosis; Vitamin B complex 10-20 mL IM. Withdrawal times: Ceftiofur (Excede) has a zero milk discard and 3-day meat withdrawal; Flunixin meglumine has a 36-hour milk discard and 4-day meat withdrawal; Oxytetracycline has a 72-hour milk discard and 28-day meat withdrawal. Always consult the label and a veterinarian for specific protocols.

Evidence-based literature on Hemorrhagic Bowel Syndrome is limited due to the sporadic nature of the disease. Key studies include: 1) A case series by Dennison et al. (2002) describing the clinical and pathological features of HBS in dairy cattle, highlighting the association with Clostridium perfringens type A and beta2 toxin. 2) A study by Godden et al. (2005) evaluating the efficacy of surgical intervention in HBS, reporting a survival rate of 50% in cows that underwent resection and anastomosis, compared to 0% in medically treated cows. 3) A retrospective study by Smith et al. (2007) identifying risk factors for HBS, including high milk production, early lactation, and feeding high-starch diets. 4) A review by Divers and Peek (2018) in Rebhun's Diseases of Dairy Cattle, summarizing the current understanding of HBS and recommending a combination of medical and surgical treatment. 5) A consensus statement from the American Association of Bovine Practitioners (AABP) on the management of acute abdominal emergencies in cattle, which includes HBS. These studies emphasize the importance of early recognition, aggressive fluid therapy, and consideration of surgical intervention. However, the evidence base is largely observational, and there is a need for more controlled studies to establish optimal treatment protocols.